Levels of endocannabinoid metabolizing enzymes are not related with BDNF levels in patients with schizophrenia: a case-controlled study
PURPOSE: While the pathogenesis of schizophrenia has yet to be fully clarified, a huge amount of data suggests the involvement of endocannabinoid system and neurotrophic factors in schizophrenia. Nevertheless, only a very limited number of studies have investigated these two systems together. With t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
AVES
2019-10-01
|
| Series: | Psychiatry and Clinical Psychopharmacology |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/24750573.2018.1540200 |